Moderator of 1 Session
It takes a village: Interdisciplinary management of patients with advanced cervical cancer - Industry Symposium by Seagen Inc. & Genmab
Session Description:
•Increased knowledge regarding:
*Clinical data for the FDA Approved and newer therapies in advanced and recurrent/metastatic Cervical Cancer
*The current investigational agents and regimens under evaluation for early, advanced, and recurrent/metastatic Cervical Cancer
•Greater competence related to:
*Selecting therapies and treatments for women with advanced and recurrent/metastatic Cervical Cancer
*Understanding on appropriate Biomarkers
*Understanding antibody drug conjugate technology (ADCs)
*Reducing treatment related issues and proactively managing side effects.
•Greater confidence in their ability to:
*Counsel patients with Cervical cancer on available therapies
*Obtaining the patient perspective
*Discuss options with your pharmacist.